Estimating vaccine efficacy during open-label follow-up of COVID-19 vaccine trials based on population-level surveillance data is a research paper published in Epidemics (2024). On theSindex it has a DataRank of 0.104. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Allergy and Infectious Diseases
Grant: 3UM1 AI068618-18S1
NIAID NIH HHS
Grant: U01 AI069470
NIAID NIH HHS
Grant: UM1 AI068635
NIAID NIH HHS
Grant: UM1 AI069470
National Institutes of Health
Grant: 3UM1AI068635-17S4
CoVPN 3001 - A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults.
FWCI
0.29
Citation Percentile
0.5%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals